GlassScriptPhysician profile
Amita Gupta
NPI 1962462630
$2,653.87
in general payments reported to CMS, 2019-2025
34 companies · $646 in 2025
The $646 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.87 · 2020: $109 · 2021: $125 · 2022: $283 · 2023: $599 · 2024: $821 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $364.31 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $307.85 | 2020-2025 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $305.79 | 2022-2025 | |
| Lilly USA, LLC | $215.61 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Teleflex LLC | $146.88 | 2025 | Barrigel |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.13 | 2023 | Lifevest |
| Pfizer INC. | $128.04 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.73 | 2020-2024 | Jardiance |
| Dexcom, INC. | $83.79 | 2023-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $76.77 | 2019-2022 | |
| Intuitive Surgical, INC. | $62.36 | 2022 | |
| Xeris Pharmaceuticals, INC. | $56.40 | 2023-2025 | Gvoke Hypopen, Keveyis |
| Janssen Pharmaceuticals, INC | $55.42 | 2021-2022 | |
| Amgen INC. | $53.77 | 2024-2025 | Repatha, Tavneos, Otezla |
| Sumitomo Pharma America, INC. | $53.43 | 2024 | Gemtesa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $50.66 | 2024 | |
| Sanofi-Aventis U.S. LLC | $40.40 | 2023 | |
| Edwards Lifesciences Corporation | $40.18 | 2025 | Sapien 3 Ultra Resilia |
| Mannkind Corporation | $39.71 | 2021 | |
| Astellas Pharma US INC | $38.88 | 2025 | Veozah |
| Shield Therapeutics INC | $36.03 | 2023-2024 | Accrufer |
| Corcept Therapeutics | $33.94 | 2022-2023 | Korlym |
| Alnylam Pharmaceuticals INC. | $22.99 | 2023 | Givlaari |
| Exact Sciences Corporation | $21.79 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $20.86 | 2022 | |
| Philips North America LLC | $20.11 | 2019 | |
| Ibsa Pharma INC. | $19.65 | 2023 | Tirosint, Licart |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.82 | 2025 | Xifaxan |
| Ultragenyx Pharmaceutical INC. | $18.16 | 2023 | |
| Medtronic Vascular, INC. | $17.88 | 2020 | |
| Glaxosmithkline, LLC. | $17.72 | 2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $15.70 | 2022 | |
| Nevro Corp. | $14.88 | 2021 | |
| Optos, INC. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amita Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.